Insider Trading History of Crombez Eric

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Crombez Eric since 2024. This trader's CIK number is 1653052. At the time of last reporting, Crombez Eric was the Officer of Abeona Therapeutics Inc.. (stock ticker symbol ABEO). Also see all insider trading activities at Abeona Therapeutics Inc..

Note that in the past Crombez Eric also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ultragenyx Pharmaceutical Inc. (RARE) by Crombez Eric

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 RARE 0 $0 9,707 $405,484 0 $0
2024 RARE 0 $0 1,734 $88,271 0 $0

Yearly summary of insider trading at Abeona Therapeutics Inc. (ABEO) by Crombez Eric

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ABEO 0 $0 4,718 $32,681 0 $0


Insider trading activities at 2 companies by Crombez Eric:

1. Ultragenyx Pharmaceutical Inc. (RARE)

2. Abeona Therapeutics Inc. (ABEO)

Table 1. Insider trading of Ultragenyx Pharmaceutical Inc. (RARE) by Crombez Eric

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-05 RARE Sale 520 39.24 20,404
2025-04-21 RARE Sale 242 35.11 8,496
2025-03-03 RARE Sale 8,945 42.10 376,584
2024-05-02 RARE Sale 354 43.66 15,455
2024-04-18 RARE Sale 142 44.10 6,262
2024-03-01 RARE Sale 1,238 53.76 66,554

Table 2. Insider trading of Abeona Therapeutics Inc. (ABEO) by Crombez Eric

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-14 ABEO Sale 4,718 6.93 32,681

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Crombez Eric (Officer of Abeona Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.